Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06450392 · ClinicalTrials.gov registry record · Phase 4
The Effect of Local and Systemic Tranexamic Acid on Edema and Ecchymosis in Orbital Surgery
A Phase 4 study of Orbital Edema and Orbital Ecchymosis, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06450392 is a Phase 4 study of Orbital Edema and Orbital Ecchymosis that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06450392, a Phase 4 study of Orbital Edema and Orbital Ecchymosis, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Tranexamic acid (TXA) is a synthetic reversible competitive inhibitor to plasminogen lysine receptor, which prevents plasmin formation and stabilizes the fibrin matrix, thus reducing bleeding. While recent studies have demonstrated the antifibrinolytic benefits of TXA in obstetric and gynecologic conditions, traumatic hemorrhage, cardiac surgery, total knee arthroplasty, and more, there is a paucity of clinical data on TXA use in plastic surgery. The aim of this study is to evaluate the effect of local and systemic TXA on postoperative periocular ecchymosis/edema in orbital surgery.
Conditions Studied
Interventions
- DRUG Tranexamic acid injection
- DRUG Tranexamic Acid in NaCl,Iso-Os 1,000 Mg/100 mL (10 Mg/mL) INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)
- DRUG normal saline - injection
- DRUG normal saline - intravenous
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-10-07 |
| Est. Completion | 2027-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06450392
The ClinicalTrials.gov registry entry for NCT06450392 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Orbital Edema appearing as the primary indexed condition, and to 4 interventions - of which Tranexamic acid injection is the first listed.
NCT06450392 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06450392 about?
NCT06450392 is a clinical study titled "The Effect of Local and Systemic Tranexamic Acid on Edema and Ecchymosis in Orbital Surgery". Tranexamic acid (TXA) is a synthetic reversible competitive inhibitor to plasminogen lysine receptor, which prevents plasmin formation and stabilizes the fibrin matrix, thus reducing bleeding. While recent studies have demonstrated the antifibrinolytic benefits of TXA in obstetric and gynecologic co...
What is the current status of trial NCT06450392?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2024-10-07. Estimated completion is 2027-01.
What conditions does trial NCT06450392 study?
This clinical trial studies the following conditions: Orbital Edema, Orbital Ecchymosis.
What interventions are being tested in trial NCT06450392?
The interventions under investigation include: Tranexamic acid injection (DRUG), Tranexamic Acid in NaCl,Iso-Os 1,000 Mg/100 mL (10 Mg/mL) INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML) (DRUG), normal saline - injection (DRUG), normal saline - intravenous (DRUG).
Who is sponsoring clinical trial NCT06450392?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06450392 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.